Drugs / Lignocain
last change Dec 2023 re-read 9 days ago

Lignocain

Developed for
cardiac rhythm disease · hypertensive disorder

Trials 0

PhaseRegistry idDatesIndicationSponsorStatusOutcome
Comparator or background therapy2 trials
Phase 2/3 NCT07385040 Comparator Apr → Dec 2023 cardiac rhythm disease, hypertensive disorder Shaheed Mohtarma Benazir Bhutto Institue of Trauma Completed No outcome recorded
— NCT02497326 Comparator Apr → Dec 2015 — King Edward Medical University Unknown No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 2 sources stand behind the page.

FieldValueCited text
Known as Lignocain ClinicalTrials.gov intervention name — accepted as the source's own label NCT02497326 ↗
1

NCT07385040 ↗

Route Topical “will be applied on superficial PTB area” NCT02497326 ↗